I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Verdaguer Mata, Helena
42
results:
Search for persons
X
Format
Online (42)
Mediatypes
Articles (Online) (30)
OpenAccess-fulltext (12)
Languages
english (38)
more...
spanish (2)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Phase 2 trial of bintrafusp alfa as second-line therapy for..:
Yoo, Changhoon
;
Javle, Milind M.
;
Verdaguer Mata, Helena
...
Hepatology. 78 (2023) 3 - p. 758-770 , 2023
Link:
https://doi.org/10.1097/..
?
2
Phase 2 trial of bintrafusp alfa as second-line therapy for..:
Yoo, Changhoon
;
Javle, Milind M
;
Verdaguer Mata, Helena
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442127/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
3
Human Metastatic Cholangiocarcinoma Patient-Derived Xenogra..:
Serra Camprubi, Queralt
;
Verdaguer Mata, Helena
;
Oliveros, Winona
...
Clinical Cancer Research;29(2). , 2023
Link:
https://hdl.handle.net/1..
?
4
Phase 2 trial of bintrafusp alfa as second-line therapy for..:
Yoo, Changhoon
;
Javle, Milind M
;
Verdaguer Mata, Helena
...
https://discovery.ucl.ac.uk/id/eprint/10174868/7/Bridgewater_%20Phase%202%20trial%20of%20bintrafusp%20alfa%20as%20second-line%20therapy%20for%20patients%20with%20locally%20advanced_metastatic%20biliary%20tract%20cancers_VoR.pdf. , 2023
Link:
https://discovery.ucl.ac..
?
5
Advances in the systemic treatment of therapeutic approache..:
Mirallas Viñas, Oriol
;
López-Valbuena, D
;
García Illescas, David
...
ESMO Open;7(3). , 2022
Link:
https://hdl.handle.net/1..
?
6
Phase I, multicenter, open-label study of intravenous VCN-0..:
Bazan-Peregrino, Miriam
;
Gil Martín, Marta
;
Álvarez, Rafael
...
Journal for ImmunoTherapy of Cancer;10(3). , 2022
Link:
https://hdl.handle.net/1..
?
7
Molecular profile and its clinical impact of IDH1 mutated v..:
Rimini, Margherita
;
Burgio, Valentina
;
Niger, Monica
...
Scientific Reports;12. , 2022
Link:
https://hdl.handle.net/1..
?
8
Quality of life of patients with metastatic pancreatic aden..:
Laquente, Berta
;
Macarulla Mercadé, Teresa
;
Cristina Bugés
...
BMC Palliative Care;19. , 2020
Link:
https://hdl.handle.net/1..
?
9
ICO-ICS Praxi per al tractament mèdic i amb irradiació de l..:
Arribas Garcia, Lorena
;
Berenguer Frances, Miguel Angel
;
Calvo-Campos, Mariona
...
ICO-ICSPraxi;. , 2018
Link:
https://hdl.handle.net/1..
?
10
Analysis of mutant allele fractions in driver genes in colo..:
Elez Fernandez, Mª Elena
;
Argilés Martinez, Guillem
;
Matos Garcia, Ignacio
...
Molecular Oncology;11(9). , 2017
Link:
https://hdl.handle.net/1..
?
11
Análisis de un panel genîmico predictivo de respuesta en en..:
Verdaguer i Mata, Helena
http://hdl.handle.net/10803/675176. , 2022
Link:
http://hdl.handle.net/10..
?
12
Análisis de un panel genîmico predictivo de respuesta en en..:
Verdaguer i Mata, Helena
Programa de Doctorat en Medicina. , 2022
Link:
https://ddd.uab.cat/reco..
?
13
362 Association of neutrophil-to-lymphocyte ratio and plate..:
Yong Liu
;
Richard Hubner
;
Ruiqi Huang
...
https://doaj.org/toc/2051-1426. , 2021
Link:
https://doi.org/10.1136/..
?
14
Clinical Outcomes After Progression on First-Line Therapies..:
Rimini, Margherita
;
Fabregat-Franco, Carles
;
Persano, Mara
...
Targeted Oncology. 18 (2023) 1 - p. 139-145 , 2023
Link:
https://doi.org/10.1007/..
?
15
ACT-Discover: identifying karyotype heterogeneity in pancre..:
Huebner, Ariana
;
Black, James R. M.
;
Sarno, Francesca
...
Genome Medicine. 15 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
1-15